Molecular mechanisms for insulin resistance in treated HIV-infection.
about
Diagnosing and managing diabetes in HIV-infected patients: current conceptsHIV protease inhibitors act as competitive inhibitors of the cytoplasmic glucose binding site of GLUTs with differing affinities for GLUT1 and GLUT4Isoform-selective inhibition of facilitative glucose transporters: elucidation of the molecular mechanism of HIV protease inhibitor binding.Molecular mechanisms of liver fibrosis in HIV/HCV coinfectionAntiretroviral therapy modifies the genetic effect of known type 2 diabetes-associated risk variants in HIV-infected women.Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.Insulin resistance, lipodystrophy and cardiometabolic syndrome in HIV/AIDS.Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis.Indinavir and nelfinavir inhibit proximal insulin receptor signaling and salicylate abrogates inhibition: potential role of the NFkappa B pathway.Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.Endocrinological aspects of HIV infection.Platelet function and cardiovascular risk in adult HIV-infected patients on HAART: a protocol for a systematic review and meta-analysis.Cardiovascular risk in an HIV-infected population in India.Immune reconstitution in ART treated, but not untreated HIV infection, is associated with abnormal beta cell function.Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia.
P2860
Q27014697-B2F0A322-94B3-4ED7-9CDD-44F9ADA9CD61Q28477208-0F290315-609E-44DD-A514-CBC4571AE0D2Q33718467-5C05F959-CCF9-4F0A-B8DE-844918AD968FQ33907429-0FB3F7E6-EE31-4DBE-A56D-C0E5EFE96C90Q34724872-87B9D344-2E69-471C-8932-08EAC624AF93Q36158019-5C7C0DD0-3CFE-4196-882C-7A7586C193C5Q38108736-10381345-F0D8-4D3E-8E4A-F924FC581323Q41993494-7BE92DBC-E2A1-42B7-BA15-E4A8AD012450Q42825813-3D15076A-BE77-45D8-8BE9-6F2B62BF66A1Q43865605-3A85C788-9D05-41DB-9E78-CA36DF933912Q47219853-BF500FE9-1F26-47D3-A638-92B22CA9569DQ47278850-0CC4602A-492B-46FB-B94C-D7F058B0CA96Q50318965-3059958E-F731-4757-BB54-150B01F8AFFAQ55342018-B1361873-3E69-468F-A35F-C6037548CBF9Q55363508-DBE0BB83-1002-4AAC-BE0E-6C57C3714A27
P2860
Molecular mechanisms for insulin resistance in treated HIV-infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms for insulin resistance in treated HIV-infection.
@en
Molecular mechanisms for insulin resistance in treated HIV-infection.
@nl
type
label
Molecular mechanisms for insulin resistance in treated HIV-infection.
@en
Molecular mechanisms for insulin resistance in treated HIV-infection.
@nl
prefLabel
Molecular mechanisms for insulin resistance in treated HIV-infection.
@en
Molecular mechanisms for insulin resistance in treated HIV-infection.
@nl
P2860
P1476
Molecular mechanisms for insulin resistance in treated HIV-infection.
@en
P2093
Paul W Hruz
P2860
P304
P356
10.1016/J.BEEM.2010.10.017
P577
2011-06-01T00:00:00Z